A patient with a germline SDHB mutation presenting with an isolated pituitary macroprolactinoma
Symptomatic pituitary adenomas occur with a prevalence of approximately 0.1% in the general population. It is estimated that 5% of pituitary adenomas occur in a familial setting, either in isolated or syndromic form. Recently, loss-of-function mutations in genes encoding succinate dehydrogenase subu...
Egile Nagusiak: | Michelle Maher, Federico Roncaroli, Nigel Mendoza, Karim Meeran, Natalie Canham, Monika Kosicka-Slawinska, Birgitta Bernhard, David Collier, Juliana Drummond, Kassiani Skordilis, Nicola Tufton, Anastasia Gontsarova, Niamh Martin, Márta Korbonits, Florian Wernig |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
Bioscientifica
2018-07-01
|
Saila: | Endocrinology, Diabetes & Metabolism Case Reports |
Sarrera elektronikoa: | https://www.edmcasereports.com/articles/endocrinology-diabetes-and-metabolism-case-reports/10.1530/EDM-18-0078 |
Antzeko izenburuak
-
An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of paraganglioma or pheochromocytoma
nork: Ali S. Alzahrani, et al.
Argitaratua: (2023-12-01) -
Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
nork: Lambert, K, et al.
Argitaratua: (2017) -
Macroprolactinomas and nonfunctioning pituitary adenomas and pregnancy outcomes
nork: Lambert, K, et al.
Argitaratua: (2017) -
Germline SDHB and SDHD mutations in pheochromocytoma and paraganglioma patients
nork: Yiqiang Huang, et al.
Argitaratua: (2018-11-01) -
Use of SDHB immunohistochemistry to identify germline mutations of SDH genes
nork: Gill AJ
Argitaratua: (2012-04-01)